DrugSupplement
Tricaprylin clinical trials
Also written Tricaprilin, AC-1204 and AC-1202.
- studies test it
- 18
- open now
- 1
- in phase 3
- 4
- first study started
- 2004
Keep track of what changes. Save the tricaprylin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Brand
Other names
Combined with it in one product
Studies by the year they started
17 studies that test it; most in 2016 (3)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2013 | 2 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 6
- Phase 2
- 5
- Phase 3
- 4
- No phase
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 13 · Other 5
Cerecin (13) · Université de Sherbrooke (1) · Weill Medical College of Cornell University (1) · University of Miami (1) · University of Zurich (1) · Hvidovre University Hospital (1)
Often tested with
Tested in the same studies.
Caprylidene (2) · Coconut Oil (1) · AC-1202 (1) · Octanoic acid (1) · Olive Oil (1)
Studies
Open first, then newest update. How each study uses tricaprylin is read from its arms, and is right about nine times in ten.
Testing it · 18
- Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) StudyNot yet recruitingPhase 3CerecinNCT05809908Written as Tricaprilin
- Tricaprilin Infantile Spasms Pilot StudyCompletedPhase 1CerecinNCT04727970Written as Tricaprilin
- Tricaprilin Phase 2 Pilot Study in MigraineCompletedPhase 2CerecinNCT04437199Written as Tricaprilin
- A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label ExtensionWithdrawnPhase 3CerecinNCT04187547Written as Tricaprilin
- AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label ExtCompletedPhase 2/3CerecinNCT01741194Written as AC-1204
- Tricaprilin in Mild to Moderate Alzheimer's DiseaseCompletedPhase 2CerecinNCT00142805Written as Tricaprilin
- Tricaprilin In Age-Associated Memory ImpairmentCompletedPhase 2CerecinNCT00355550Written as Tricaprilin
- Study to Compare the Pharmacokinetics of Tricaprilin Formulations and a Placebo on Ketone Body ProductionCompletedPhase 1CerecinNCT03971123Written as Tricaprilin
- Study to Compare the Pharmacokinetics of Daily Administration of Tricaprilin on Ketone Body ProductionCompletedPhase 1CerecinNCT04268953Written as Tricaprilin
- Comparing the Ketogenic Effect of Coconut Oil and Different MCTsCompletedNot applicableUniversité de SherbrookeNCT02679222Written as Coconut oil + tricaprylin
- Taste-masking Study for Tricaprilin in Sensory PanelistsCompletedPhase 1CerecinNCT03628352Written as Tricaprilin
- Safety of Caprylic Triglycerides in ALS: A Pilot StudyCompletedNot applicableWeill Medical College of Cornell UniversityNCT02716662Written as Axona
- Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple SclerosisCompletedNot applicableUniversity of MiamiNCT01848327Written as Caprylic Triglyceride
- Fat Metabolites and Gut HormonesStatus unknownNot applicableHvidovre University HospitalNCT03223389Written as Tricaprylin
- Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body ProductionCompletedPhase 1CerecinNCT02833012Written as Axona
- Evaluation of PK of AC1204 v Caprylic Triglyceride Oil Incl Food Effect on Ketone Body ProductionCompletedPhase 1CerecinNCT02747602Written as AC-1204
- 13C Trioctanoate Breath Test as a Measurement of Gastric Fat Volume EmptyingCompletedEarly Phase 1University of ZurichNCT02602158Written as TRIOCTANOIN (1,1,1-13C3, 99%)
- AC-1204 Long-term Efficacy Response Trial (ALERT Protocol)WithdrawnPhase 2/3CerecinNCT01211782Written as caprylic triglyceride
Given in every arm · 1 — tricaprylin is usual care beside what is tested
Codes
What other systems call tricaprylin · ClinicalTrials.gg INT002277
- MeSH (NLM) C003637tricaprylinConfirmed NLM, Wikidata
- UNII (FDA) 6P92858988TRICAPRILINConfirmed FDA, NLM, Wikidata
- RxNorm 1314420Confirmed FDA, Wikidata
- Wikidata Q2747851tricaprylinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29861TricaprylinOne source FDA
- DrugBank DB12176One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C003637 | tricaprylin | Confirmed NLM, Wikidata |
| UNII (FDA) | 6P92858988 | TRICAPRILIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1314420 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2747851 | tricaprylin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29861 | Tricaprylin | One source FDA |
| DrugBank | DB12176 | — | One source Wikidata |
Also registered as triethylhexanoin (UNII 7K3W1BIU6K · RxNorm 1368189).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.